SiauK, ChapmanW, SharmaN. Management of acute upper gastrointestinal bleeding: an update for the general physician. J R Coll Physicians Edinb2017; 47: 218–30.
2.
EikelboomJW, ConnollySJ, BoschJ. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med2017; 377: 1319–30.
3.
SiauK, HannahJL, HodsonJ. Stopping antithrombotic therapy after acute upper gastrointestinal bleeding is associated with reduced survival. Postgrad Med J2017. Epub ahead of print 3 November.
4.
StaerkL, LipGYH, OlesenJB. Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. BMJ2015;351.
5.
MaggioD, BarkunAN, MartelM. Predictors of early rebleeding after endoscopic therapy in patients with nonvariceal upper gastrointestinal bleeding secondary to high-risk lesions. Can J Gastroenterol2013; 27: 454–8.
6.
QureshiW, MittalC, PatsiasI. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. Am J Cardiol2014; 113: 662–8.
